Abstract
The clinical triad of bradykinesia, tremor and rigidity is felt to be sufficient to diagnose idiopathic Parkinson’s disease, the assumption being made that the underlying pathology is centred on the zona compacta of the substantia nigra. That assumption is probably correct in the majority of patients with this clinical picture, though it is likely that other neuropathological disorders, generally undiagnosable in life, can present with a similar pattern of disability. Drug-induced Parkinsonism may be indistinguishable from the idiopathic form, though tremor is less conspicuous. The clinical spectrum of post-encephalitic Parkinsonism is broader, whilst extrapyramidal features are only a part of the disorder accruing from multi-infarction. The frequency with which dementia occurs in Parkinson’s disease, and its severity, remains a matter of debate. One reviewer has suggested that one third of Parkinsonian patients become demented in the later stages of the disease [1], based on a study which recorded moderate to marked dementia in 32% of 520 patients [2]. Included among these patients, however, were some with atypical features (wasting, cerebellar tremor, dystop1a or pyramidal signs), though, even in these, the parkinsonian features predominated. Though the authors claimed that dementia was as likely in the typical as in the atypical cases, another paper, including 93 patients, came to the opposite conclusion. There, an organic mental syndrome (principally dementia) was found in 15% of typical but in 68% of atypical cases [3].
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Marsden, C.D. (1982) Basal ganglia disease. Lancet, ii, 1141–7.
Lieberman, A, Dziatolowski, M., Kupersmith, M. et al. (1979) Dementia in Parkinson disease. Ann. Neurol., 6, 355–9.
Sroka, H., Elizan, T.S., Yahr, M.D. et al. (1981) Organic mental syndrome and confusional states in Parkinson’s disease. Arch. Neurol., 38, 339–42.
Esteban, A. and Giménez-Roldân, S. (1975) Blink reflex in Hunting-ton’s chorea and Parkinson’s disease. Acta Neurol. Scand., 52, 145–57.
Gawel, M.J., Das, P., Vincent, S. and Rose, F.C. (1981) Visual and auditory evoked responses in patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry, 44, 227–32.
Kupersmith, M.J., Shakin, E., Siegel, I.M. and Lieberman, A. (1982) Visual system abnormalities in patients with Parkinson’s disease. Arch. Neurol., 39, 284–6.
Dinner, D.S., Luders, H., Hanson, M. et al. (1985) Pattern evoked potentials (PEPs) in Parkinson’s disease. Neurology, 35, 610–13.
Williams, A., Houff, S., Lees, A. and Calne, D.B. (1979) Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic Parkinsonism. J. Neurol. Neurosurg. Psychiatry, 42, 790–2.
Behan, P.O., Thomas, A.M. and Behan, W.M.H. (1981) Cerebrospinal fluid immunoglobulin profiles in Parkinson’s disease. in Research Progress in Parkinson’s Disease (ed. F.C. Rose and R. Capildeo ), Pitman Medical, London, pp. 181–5.
Johansson, B. and Roos, B-E. (1967) 5-Hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson’s syndrome. Life Sci., 6, 1449–54.
Abbott, R.J., Pye, I.F. and Nahorski, S.R. (1982) CSF and plasma GABA levels in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry, 45, 253–6.
Nutt, J.G., Mroz, E.A., Leeman, S.E. et al. (1980) Substance Pin human cerebrospinal fluid: Reductions in peripheral neuropathy and autonomic dysfunction. Neurology, 30, 1280–5.
Gath, I., Jörgensen, A., Sjaastad, O. and Berstad, J. (1975) Pneumoencephalographic findings in Parkinsonism. Arch. Neurol., 32, 769–73.
Mayeux, R., Stern, Y., Rosen, J. and Benson, D.F. (1981) Subcortical dementia: A recognizable clinical entity. Ann. Neurol., 10, 100–1.
Wolfson, L.I., Leenders, K.L., Brown, L.L. and Jones, T. (1985) Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson’s disease. Neurology, 35, 1399–405.
Nahmias, C., Garnett, E.S., Firnau, G. and Lang, A. (1985) Striatal dopamine distribution in Parkinsonian patients during life. J. Neurol. Sci., 69, 223–30.
Starr, A. (1967) A disorder of rapid eye movements in Huntington’s chorea. Brain, 90, 545–64.
Scott, D.F., Heathfield, K.W.G., Toone, B. and Margerison, J.H. (1972) The EEG in Huntington’s chorea: a clinical and neuropathological study. J. Neurol. Neurosurg. Psychiatry, 35, 97–102.
Ellenberger, C. Jr, Petro, D.J. and Ziegler, S.B. (1978) The visually evoked potential in Huntington’s disease. Neurology, 28, 95–7.
Wilson, R.S. and Garron, D.C. (1979) Cognitive and affective aspects of Huntington’s disease. In Advances in Neurology, Vol. 23 (ed. T.N. Chase, N.S. Wexler and A. Barbeau ), Raven Press, New York, pp. 193–201.
Bala Manyam, N.V., Hare, T.A. and Katz, L. (1979) Cerebrospinal fluid GABA levels in Huntington’s disease, `at risk’ for Huntington’s disease and normal controls. in Advances in Neurology, Vol. 23 (ed. T.N. Chase, N.S. Wexler and A. Barbeau ), Raven Press, New York, pp. 547–56.
Cramer, H., Kohler, J., Oepen, G. et al. (1981) Huntington’s chorea–measurements of somatostatin, substance P and cyclic nucleotides in the cerebrospinal fluid. J. Neurol., 225, 183–7.
Barr, A.N., Heinze, W.J., Dobben, G.D. et al. (1978) Bicaudate index in computerized tomography of Huntington’s disease and cerebral atrophy. Neurology, 28, 1196–200.
Martin, W.R.W., Hayden, M.R., Suchowersky, O. et al. (1984) Striatal metabolism in Huntington’s disease and in benign hereditary chorea. Ann. Neurol., 16, 126.
Patterson, R.M., Bagchi, B.K. and Test, A. (1948) The prediction of Huntington’s chorea. An electroencephalographic and genetic study. Am. J. Psychiatry, 104, 786–97.
Chandler, J.H. (1966) EEG in prediction of Huntington’s chorea. An eighteen year follow-up. Electroencephalogr. Clin. Neurophysiol., 21, 79–80.
Esteban, A., Mateo, D. and Giménez-Roldân, S. (1981) Early detection of Huntington’s disease. Blink reflex and levodopa load in presymptomatic and incipient subjects. J. Neurol. Neurosurg. Psychiatry, 44, 43–8.
Oepen, G. and Ostertag, Ch. (1981) Diagnostic value of CT in patients with Huntington’s chorea and their offspring. J. Neurol., 225, 189–96.
Klawans, H.L. Jr, Paulson, G.W., Ringel, S.P. and Barbeau, A. (1972) Use of L-dopa in the detection of presymptomatic Huntington’s chorea. N. Engl. J. Med., 286, 1332–4.
Klawans, H.L., Goetz, C.G., Paulson, G.W. and Barbeau, A. (1980) Levodopa and presymptomatic detection of Huntington’s disease - eight-year follow-up. N. Engl. J. Med., 302, 1090.
Young, A.B., Penney, J.B., Starosta-Rubinstein, S. et al. (1987) Normal caudate glucose metabolism in persons at risk for Huntington’s disease. Arch. Neurol., 44, 254–7.
Gusella, J.F., Wexler, N.S., Conneally, P.M. et al. (1983) A polymorphic DNA marker genetically linked to Huntington’s disease. Nature, 306, 234–8.
Richardson, J.C., Steele, J. and Olszewski, J. (1963) Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. Trans. Am. Neurol. Assoc., 88, 25–7.
Albert, M.L., Feldman, R.G., and Willis, A.L. (1974) The `subcortical dementia’ of progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry, 37, 121–30.
Perkin, G.D., Lees, A.J., Stern, G.M. and Kocen, R.S. (1978) Problems in the diagnosis of progressive supranuclear palsy (Steele-RichardsonOlszewski syndrome). Can. J. Neurol. Sci., 5, 167–73.
Pfaffenbach, D.D., Layton, D.D. and Kearns, T.P. (1972) Ocular manifestations in progressive supranuclear palsy. Am. J. Ophthalmol., 74, 1179–84.
Haldeman, S., Goldman, J.W., Hyde, J. and Pribram, H.F.W. (1981) Progressive supranuclear palsy, computed tomography and response to antiparkinsonian drugs. Neurology, 31, 442–5.
Baron, J.C., Maziere, B., Loch, C. et al. (1985) Progressive supranuclear palsy: loss of striatal dopamine receptors demonstrated in vivo by positron tomography. Lancet, 1, 1163–4.
Strickland, G.T. and Leu, M-L. (1975) Wilson’s disease. Clinical and laboratory manifestations in 40 patients. Medicine (Baltimore), 54, 113–37.
Ross, M.E., Jacobson, I.M., Dienstag, J.L. and Martin, J.B. (1985) Late-onset Wilson’s disease with neurological involvement in the absence of Kayser-Fleischer rings. Ann. Neurol., 17, 411–13.
Roach, E.S., Ford, C.S., Spudis, E.V. et al. (1985) Wilson’s disease: evoked potentials and computed tomography. J. Neurol., 232, 20–3.
Williams, F.J.B. and Walshe, J.M. (1981) Wilson’s disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents. Brain, 104, 735–52.
Lawler, G.A., Pennock, J.M., Steiner, R.E. et al. (1983) Nuclear magnetic resonance (NMR) imaging in Wilson’s disease. J. Comput. Assist. Tomogr., 7, 1–8.
Marsden, C.D. (1976) Dystonia: the spectrum of the disease. in The Basal Ganglia (ed. M.D. Yahr ), Raven Press, New York, pp. 351–67.
Marsden, C.D., Obeso, J.A., Zarranz, J.J. and Lang, A.E. (1985) The anatomical basis of symptomatic hemidystonia. Brain, 108, 463–83.
Bodensteiner, J.B., Goldblum, R.M. and Goldman, A.S. (1980) Progressive dystonia masking ataxia in ataxia-telangiectasia. Arch. Neurol., 37, 464–5.
Neville, B.G.R., Lake, B.D., Stephens, R. and Sanders, M.D. (1973) A neurovisceral storage disease with vertical supranuclear ophthalmoplegia, and its relationship to Niemann—Pick disease. A report of nine patients. Brain, 96, 97–120.
Longstreth, W.T. Jr, Farrell, D.F., Bolen, J.W. et al. (1982) Adult dystonic lipidosis: clinical, histologic, and biochemical findings of a neurovisceral storage disease. Neurology, 32 (2), A141.
Dooling, E.C., Schoene, W.C. and Richardson, E.P. Jr (1974) Hallervorden—Spatz syndrome. Arch. Neurol., 30, 70–83.
Hall, K. and Gardner-Medwin, D. (1978) CT scan appearances in Leigh’s disease (subacute necrotizing encephalomyelopathy). Neuro-radiology, 16, 48–50.
Marsden, C.D., Lang, A.E., Quinn, N.P. et al. (1986) Familial dystonia and visual failure with striatal CT lucencies. J. Neurol. Neurosurg. Psychiatry, 49, 500–9.
Aminoff, M.J. (1972) Acanthocytosis and neurological disease. Brain, 95, 749–60.
Larsen, T.A., Dunn, H.G., Jan, J.E. and Calne, D.B. (1985) Dystonia and calcification of the basal ganglia. Neurology, 35, 533–7.
Fahn, S., Marsden, C.D. and Calne, D.B. (1987) Classification and investigation of dystonia. in Movement Disorders, 2 (ed. C.D. Marsden and S. Fahn ), Butterworths, London, pp. 332–58.
Lang, A.E., Clarke, J.T.R., Resch, L. et al. (1985) Progressive longstanding `pure’ dystonia: a new phenotype of juvenile metachromatic leukodystrophy (MLD). Neurology, 35, (Suppl. 1), 194.
Nakano, T., Ikeda, S.-I., Kondo, K. et al. (1985) Adult GM, -gangliosidosis: clinical patterns and rectal biopsy. Neurology, 35, 875–80.
Tahmoush, A.J., Alpers, D.H., Feigin, R.D. et al. (1976) Hartnup disease. Clinical, pathological and biochemical observations. Arch. Neurol., 33, 797–807.
Schwartz, J.F., Rowland, L.P., Eder, H. et al. (1963) Bassen—Kornzweig syndrome: deficiency of serum 13-lipoprotein. Arch. Neurol., 8, 438–54.
Gross, K.B., Skrivanek, J.A., Carlson, K.C. and Kaufman, D.M. (1985) Familial amyotrophic chorea with acanthocytosis. New clinical and laboratory investigations. Arch. Neurol., 42, 753–6.
Greenhouse, A.H. (1966) On chorea, lupus erythematosus, and cerebral arteritis. Arch. Intern. Med., 117, 389–93.
Krumholz, A., Singer, H.S., Niedermeyer, E. et al. (1983) Electrophysiological studies in Tourette’s syndrome. Ann. Neurol., 14, 638–41.
Lees, A.J., Robertson, M., Trimble, M.R. and Murray, N.M.F. (1984) A clinical study of Gilles de la Tourette syndrome in the United Kingdom. J. Neurol. Neurosurg. Psychiatry, 47, 1–8.
Brainin, M., Reisner, Th. and Zeitlhofer, J. (1983) Tardive dyskinesia: clinical correlation with computed tomography in patients aged less than 60 years. J. Neurol. Neurosurg. Psychiatry, 46, 1037–40.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1988 G.D. Perkin
About this chapter
Cite this chapter
Perkin, G.D. (1988). Extra-pyramidal disease. In: Diagnostic Tests in Neurology. Diagnostic Tests Series. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3320-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3320-1_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-28400-7
Online ISBN: 978-1-4899-3320-1
eBook Packages: Springer Book Archive